戻る
MoonLake Immunotherapeutics (MLTX)価格
MLTX 株価推移チャート
MLTX 収入
MoonLake Immunotherapeutics
$16.76
2.5%
$0.41
終値： Jan 16, 16:00:00 GMT-5
$16.75
-0.05%
$-0.01
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$16.35
始値
$16.39
当日レンジ
$16.18 - $16.88
52週レンジ
$5.95 - $62.75
取引高
1.4M
平均取引高
4.5M
1株当たり利益(TTM)
-3.33
配当利回り
--
時価総額
$1.2B
MLTXとは何ですか？
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. The company is headquartered in Zug, Zug and currently employs 100 full-time employees. The company went IPO on 2020-10-20. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The firm develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.